Genotyping Assay Market is estimated to be US$ 195.98 billion by 2032 with a CAGR of 22.3% during the forecast period 2032
Genotyping Assay
Market accounted for US$ 25.5 billion in 2022 and is
estimated to be US$ 195.98 billion by 2032 and is anticipated to register a
CAGR of 22.3%. A genotyping assay is a biochemical test used in determine the
genetic makeup of an organism, the genotyping assay can identify specific
genes, mutations or chromosomal abnormalities. Genotyping is the process of
examining an individual's DNA sequence, Genetic variations can be examined
through biological testing and compared, compared to the development of other
people. Genetic anomalies such as single nucleotide polymorphisms and major
structural changes in DNA can be studied using genotyping. A genotyping assay
is mainly used method for determining DNA sequence and genetic makeup by
comparing it with other sequences. High efficiency, operational flexibility and
access to multiple parameters in a single test are some of the essential
features of modern genotyping assays. Genotyping assays are most important
because they help to study population genomics, disease associations, agronomic
traits and microorganisms. Genotyping assays can be conducted using polymerase
chain reaction (PCR), electrophoresis, microarray, and MALDI-TOF. The demand
for genotyping assays is high in segments of pharmaceutical and
biopharmaceutical companies due to the increasing demand for personalized
medicine. Factors influencing the genotyping assay market are the rising
importance of genotyping assays and technological advancements that are
expected to drive the market growth.
The report “Global
Genotyping Assay Market, By Product & Service (Reagents and Kits,
Genotyping Services, Instruments, and Bioinformatics), By Technology
(Microarrays, Sequencing, Capillary Electrophoresis, MALDI-TOF, Others), By
Application (Pharmacogenomics, Diagnostic and Personalized Medicine,
Agricultural Biotechnology, Animal Genetics, and Others) By End User
(Pharmaceutical and Biopharmaceutical Companies, Diagnostic and Research
Laboratories, Academic Institutes, and Other) , and By Region (North America,
Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends,
Analysis and Forecast till 2032 “
Key Highlights:
·
In October 2022, High Prevalence of Pfcrt
76T and Pfmdr1 N86 Genotypes in Malaria Infected Patients Attending Health
Facilities in East Shewa Zone, Oromia Regional State, Ethiopia. A genomic DNA
template was used to amplify the Pfcrt K76T and Pfmdr1 N86Y codons by nested
PCR. The nested PCR
products were subjected to Arthrobacter protoformia-I (APoI) restriction enzyme
digestion to determine mutations in codons 76 and 86 of the Pfcrt and Pfmdr1
genes, respectively.
·
In September
2022, changing patterns of genetic variation in the slender wild oat, Avena
barbata. A. barbata is an introduced species from
California, and the results suggest that the order in which genotypes were
introduced has shaped the course of contemporary evolution. While recombination
has occurred among many introduced genotypes, many evolutionary changes appear
to have resulted from the displacement of earlier colonies by well-adapted but
later-introduced genotypes.
·
In September 2021, Illumina invested in seven genomics
companies from different countries under its Illumina Accelerator program.
Analyst View:
Genotyping is
most important and useful because Genotyping is determines differences in the
genetic complement by comparing a DNA sequence to another sample or reference
sequence. It identifies small differences in the genetic sequence between
populations, such as single-nucleotide polymorphisms (SNPs). The global
genotyping assay market is increases by several factors. One of them is the
increasing number of genetic diseases worldwide and rising importance of
genotyping in drug development is expected to support market growth. Global
Genotyping Assay Market innovation is growing around the world, owing to
technology developments in genotyping assay that are more efficient to wear and
use.
Before
purchasing this report, request a sample or make an inquiry by clicking the
following link:
https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/3873
Key Market
Insights from the report:
Global
Genotyping Assay Market accounted for US$ 25.5 billion in 2022 and is estimated
to be US$ 195.98 billion by 2032 and is anticipated to register a CAGR of
22.3%. The Global Genotyping Assay Market is segmented based on Product
Service, Technology, Application, End User and Region.
·
Based on
Product and Service, Global Genotyping Assay Market is segmented into Reagents
and Kits, Genotyping Services, Instruments, and Bioinformatics.
·
Based on
Technology, Global Genotyping Assay Market is segmented into Microarrays,
Sequencing, Capillary Electrophoresis, MALDI-TOF, Others.
·
Based on
Application, Global Genotyping Assay Market is segmented into Pharmacogenomics,
Diagnostic and Personalized Medicine, Agricultural Biotechnology, Animal
Genetics, and Others.
·
Based on End
User, Global Genotyping Assay Market is segmented into Pharmaceutical and
Biopharmaceutical Companies, Diagnostic and Research Laboratories, Academic
Institutes, and Other.
·
By Region, the
Global Genotyping Assay Market is segmented into North America, Europe, Asia
Pacific, Latin America, and Middle East & Africa.
Competitive
Landscape & their strategies of Global Genotyping Assay Market:
The prominent players operating in the Global
Genotyping Assay Market includes,
Illumina, Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche Ltd, Agilent
Technologies, Inc., Danaher, Roche Diagnostics, GE Healthcare, Fluidigm
Corporation, PerkinElmer, Erofins Scientific.
The market provides detailed information
regarding the industrial base, productivity, strengths, manufacturers, and
recent trends which will help companies enlarge the businesses and promote
financial growth. Furthermore, the report exhibits dynamic factors including
segments, sub-segments, regional marketplaces, competition, dominant key
players, and market forecasts. In addition, the market includes recent
collaborations, mergers, acquisitions, and partnerships along with regulatory
frameworks across different regions impacting the market trajectory. Recent
technological advances and innovations influencing the global market are
included in the report.
About Prophecy
Market Insights
Prophecy
Market Insights is specialized market research, analytics, marketing/business
strategy, and solutions that offers strategic and tactical support to clients
for making well-informed business decisions and to identify and achieve
high-value opportunities in the target business area. We also help our clients
to address business challenges and provide the best possible solutions to
overcome them and transform their business.
To know more
Contact Us:
Sales
Prophecy Market Insights
Email- sales@prophecymarketinsights.com
Website- www.prophecymarketinsights.com
Comments
Post a Comment